Inactive Instrument
Lipidor AB Stock Nasdaq Stockholm
Stocks
LIPI
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -6.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52% | -24.56% | - | - | 92.63K | |
| -2.44% | -7.04% | +43.69% | +155.54% | 1,054B | |
| -1.91% | -5.51% | +61.02% | +57.95% | 621B | |
| -1.23% | -4.07% | +27.55% | +79.61% | 438B | |
| -1.33% | -3.98% | +26.50% | +20.21% | 325B | |
| -1.97% | -3.68% | +26.66% | +43.76% | 281B | |
| -1.70% | -13.73% | +16.23% | +20.03% | 262B | |
| -1.45% | -2.37% | -27.87% | -39.87% | 219B | |
| -1.00% | -3.03% | +20.17% | +56.94% | 195B | |
| -0.89% | -4.58% | +16.08% | +68.56% | 163B | |
| Average | -2.04% | -1.70% | +23.34% | +51.41% | 395.13B | |
| Weighted average by Cap. | -1.81% | -1.69% | +32.83% | +76.60% |
Employees
4
Sector
Pharmaceuticals
Choose MarketScreener 
